Sprache NL EN DE ES FR UK IT

Neubauanalyse

Kartellanalyse

Saubere Grundlage für MEP-, Dokument- und thematische Netzwerkanalyse. Keine harten politischen Labels, sondern überprüfbare Evidenz.

You are here

VERSLAG over het verzoek om opheffing van de immuniteit van Nils Ušakovs

You are viewing a dossier. From here you can see which actors, signals and linked vote events are visible around this document.

Jump to

Dossier Actors Sources and context Supporting layers Linked vote events

Dossier

VERSLAG over het verzoek om opheffing van de immuniteit van Nils Ušakovs

Verslag voor de plenaire vergadering van het EP | 2024-04-09 | source: plenary_documents

Open bronpagina Leesbare metadata Wikipedia zoeken

1Actors
0Signals
9EP term

Actors

Gilles Lebreton

Role: co-author
Method: name-normalized | confidence 0.7500
Sources and context Source text and aggregated content + Provenance and audit

Source text and aggregated content

VERSLAG over het verzoek om opheffing van de immuniteit van Nils Ušakovs
P9_A(2024)0167

Provenance and audit

This block makes visible which source layer and datapoints the current view is based on.

Source layer plenary_documents
Canonical identifier A-9-2024-0167
Official source URL https://data.europarl.europa.eu/eli/dl/doc/A-9-2024-0167
Title and language layer Only Dutch title available
EP term 9

News context around this event

Use these links to quickly search reputable news sources around the event date using the title and keywords.

Search period: 2024-04-09
Keywords: het verzoek om opheffing van de immuniteit van Nils Ušakovs
Reuters Financial Times Politico Europe The Guardian NRC de Volkskrant Google News
Supporting layers Signals

Signals

No signal clusters found for this topic yet.
Linked vote events Votes and seat distribution

Linked vote events

Request for the waiver of the immunity of Nils Ušakovs

2024-04-11 00:00:00 | plenary-vote-result
Key players / requesters: Gilles Lebreton [rapporteur]
No individual member positions in this official sample layer.

Next logical step

Use these routes to continue your research from this page.

Continue to topics Continue to evidence board Back to dashboard